12-11091592-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_176884.2(TAS2R43):c.638G>A(p.Gly213Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000303 in 1,321,680 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_176884.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000801 AC: 1AN: 124880Hom.: 0 Cov.: 22
GnomAD3 exomes AF: 0.0000139 AC: 3AN: 215056Hom.: 1 AF XY: 0.0000257 AC XY: 3AN XY: 116852
GnomAD4 exome AF: 0.00000251 AC: 3AN: 1196800Hom.: 0 Cov.: 56 AF XY: 0.00000332 AC XY: 2AN XY: 602712
GnomAD4 genome AF: 0.00000801 AC: 1AN: 124880Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 60862
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.638G>A (p.G213D) alteration is located in exon 1 (coding exon 1) of the TAS2R43 gene. This alteration results from a G to A substitution at nucleotide position 638, causing the glycine (G) at amino acid position 213 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at